ArticleHepatology international2026
Efficacy of tirzepatide versus SGLT2 inhibitors in metabolic dysfunction-associated steatotic liver disease (MASLD): a multicenter propensity-matched real-world study.
Ibrahim Khalil et al.PubMed ↗Publisher ↗
No numbers read from the abstract.